THE IN VITRO RELEASE MECHANISM OF IBUPROFEN FROM CONVENTIONAL AND SPECIAL DOSAGE FORMS

被引：0

作者：

Draganescu, Doina ^{[1
]}

Daniela, Elena Popa ^{[2
]}

Lupuleasa, Dumitru ^{[3
]}

Dragomiroiu, George Traian Alexandru Burcea ^{[2
]}

Daliai, Simona Miron ^{[1
]}

Rosca, Adrian Cosmin ^{[4
]}

Chivu, Razvan-Daniel ^{[5
]}

机构：

[1] Univ Med & Pharm Carol Davila Bucharest, Fac Pharm, Dept Pharmaceut Phys & Informat, Bucharest 020956, Romania

[2] Univ Med & Pharm Carol Davila Bucharest, Fac Pharm, Dept Drug Control, Bucharest 020956, Romania

[3] Univ Med & Pharm Carol Davila Bucharest, Fac Pharm, Dept Pharmaceut Technol & Biopharmaceut, Bucharest 020956, Romania

[4] Ovidius Univ Constanta, Fac Pharm, Dept Drug Control, Constanta, Romania

[5] Univ Med & Pharm Carol Davila, Fac Med Midwifery & Nursing, Bucharest, Romania

来源：

FARMACIA | 2013年 / 61卷 / 04期

关键词：

ibuprofen; modeling; in vitro dissolution test; BIOPHARMACEUTICAL CLASSIFICATION; DRUGS; DISSOLUTION; BIOEQUIVALENCE; SOLUBILITY; GUIDELINE;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Six pharmaceutical dosage forms (sugar coated tablets, hard and soft gelatin capsules, oral suspension and rectal suppositories), containing various concentrations of ibuprofen as single active ingredient, were evaluated in vitro, based on the available compendial recommendations. Several methodological adaptions were implemented, in order to adequately address the particularities of the formulations and the rate-limiting step of the release process. The analysis of the mean dissolution profiles was focused on applicability of different kinetic models, possible explanations for observed similarities or non-similarities and on the foreseen limitations in applicability of the test conditions, in the context of biowaiver.

引用

页码：811 / 819

页数：9

共 50 条

[21] Study of In Vitro Drug Release and Percutaneous Absorption of Fluconazole from Topical Dosage Forms
Salerno, Claudia
Carlucci, Adriana M.
Bregni, Carlos
AAPS PHARMSCITECH, 2010, 11 (02): : 986 - 993
[22] Kinetics of release of theophylline from sustained release dosage forms
Gupta, S.
Pandey, A.
OXIDATION COMMUNICATIONS, 2007, 30 (01): : 192 - 196
[23] Quercetin topical application, from conventional dosage forms to nanodosage forms
Hatahet, T.
Morille, M.
Hommoss, A.
Devoisselle, J. M.
Mueller, R. H.
Begu, S.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2016, 108 : 41 - 53
[24] Non-solvent shock agglomerated ibuprofen:: Production and evaluation of quick release dosage forms
Möller, T
Korsatko, W
PHARMAZIE, 2000, 55 (01): : 53 - 58
[25] In vitro in vivo relationship of oral extended-release dosage forms
Liu, FY
Sambol, NC
Giannini, RP
Liu, CY
PHARMACEUTICAL RESEARCH, 1996, 13 (10) : 1501 - 1506
[26] Investigation of the utility of an in vitro release test for optimizing semisolid dosage forms
Proniuk, S
Dixon, SE
Blanchard, J
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2001, 6 (03) : 469 - 476
[27] A biorelevant in vitro release/permeation system for oral transmucosal dosage forms
Delvadia, Poonam R.
Barr, William H.
Karnes, H. Thomas
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 430 (1-2) : 104 - 113
[28] Active compounds release from semisolid dosage forms
Olejnik, Anna
Goscianska, Joanna
Nowak, Izabela
JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (11) : 4032 - 4045
[29] RELEASE OF LIDOCAINE FROM POLYMER FILM DOSAGE FORMS
DANJO, K
HIGUCHI, F
OTSUKA, A
CHEMICAL & PHARMACEUTICAL BULLETIN, 1995, 43 (10) : 1759 - 1763
[30] Controlled release dosage forms: From ground to space
Colombo, P
Bettini, R
Peracchia, MT
Santi, P
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1996, 21 (02) : 87 - 91

← 1 2 3 4 5 →